S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
$24.04
$24.02
$8.42
$24.25
$1.76B3.022.70 million shsN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$30.31
+2.9%
$28.18
$23.10
$53.50
$721.08M1.16185,539 shs137,299 shs
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$5.28
+0.6%
$6.52
$4.38
$8.45
$403.97M0.15897,853 shs660,424 shs
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$15.42
+0.8%
$17.20
$14.84
$29.51
$633.15M1.2438,776 shs587,572 shs
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$68.58
+2.0%
$70.17
$66.90
$100.59
$246.20M0.1226,907 shs42,931 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
0.00%0.00%0.00%0.00%0.00%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-1.47%-6.65%+10.71%+2.15%-38.59%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
0.00%-9.01%-21.99%-32.52%-23.69%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
+0.46%-2.49%-5.26%-17.48%-29.56%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
-0.58%-4.18%-2.41%-17.81%-29.23%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
4.0589 of 5 stars
3.41.00.03.92.84.20.6
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
4.0146 of 5 stars
2.25.00.04.21.81.71.9
SI-BONE, Inc. stock logo
SIBN
SI-BONE
4.2409 of 5 stars
4.52.00.03.31.72.50.6
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
3.2188 of 5 stars
0.05.01.74.22.51.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
N/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.75
Moderate Buy$42.5040.22% Upside
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
2.33
Hold$6.3820.74% Upside
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.00
Buy$26.6772.94% Upside
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/AN/AN/AN/A

Current Analyst Ratings

Latest OSUR, SIBN, UTMD, KIDS, and GNMK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00
4/4/2024
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$7.00 ➝ $6.50
4/3/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$27.00
3/28/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$25.00
3/7/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$50.00
2/27/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$25.00 ➝ $26.00
2/27/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$25.00
2/27/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$26.00 ➝ $24.00
1/25/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$39.00 ➝ $31.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
$88.02M19.96N/AN/A$0.21 per share114.48
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$148.73M4.85N/AN/A$16.14 per share1.88
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$405.47M1.00$1.35 per share3.92$5.86 per share0.90
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$138.89M4.56N/AN/A$4.18 per share3.69
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$50.22M4.90$6.43 per share10.67$35.35 per share1.94

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
-$47.35M-$0.82N/AN/AN/A-16.95%-39.36%-13.02%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$20.97M-$0.92N/AN/AN/A-14.10%-5.03%-4.37%5/6/2024 (Estimated)
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$53.65M$0.727.33N/AN/A13.23%14.50%12.69%5/8/2024 (Estimated)
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$43.34M-$1.14N/AN/AN/A-31.20%-28.22%-20.53%5/6/2024 (Confirmed)
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$16.64M$4.5715.01N/A33.12%13.53%12.68%4/23/2024 (Estimated)

Latest OSUR, SIBN, UTMD, KIDS, and GNMK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.29N/A+$0.29N/AN/AN/A  
3/6/2024Q4 2023
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.28-$0.23+$0.05-$0.17$37.59 million$37.61 million
2/27/2024Q4 2023
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$0.13$0.22+$0.09$0.17$74.13 million$75.88 million    
2/26/2024Q4 2023
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.29-$0.27+$0.02-$0.27$38.60 million$38.86 million
1/30/2024Q4 2023
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A$1.18+$1.18$1.18N/A$12.33 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/AN/AN/AN/AN/A
SI-BONE, Inc. stock logo
SIBN
SI-BONE
N/AN/AN/AN/AN/A
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$1.201.75%+1.75%26.26%2 Years

Latest OSUR, SIBN, UTMD, KIDS, and GNMK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2024
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
quarterly$0.301.6%3/14/20243/15/20244/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
0.75
4.33
3.84
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.03
5.44
2.90
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/A
9.77
8.57
SI-BONE, Inc. stock logo
SIBN
SI-BONE
0.21
9.01
8.15
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A
22.56
20.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
96.94%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
93.50%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
98.11%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
69.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
GenMark Diagnostics, Inc. stock logo
GNMK
GenMark Diagnostics
61873.09 millionN/AOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
24723.79 million16.03 millionOptionable
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
63876.51 million73.91 millionOptionable
SI-BONE, Inc. stock logo
SIBN
SI-BONE
34441.06 million38.85 millionOptionable
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
1693.59 million3.36 millionNot Optionable

OSUR, SIBN, UTMD, KIDS, and GNMK Headlines

SourceHeadline
Utah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-savingUtah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-saving'
msn.com - April 19 at 7:30 AM
Fairmat opens first U.S. industrial facility in UtahFairmat opens first U.S. industrial facility in Utah
compositesworld.com - April 18 at 3:57 PM
Hurdles in Utah push medical cannabis patients toward out-of-state products.Hurdles in Utah push medical cannabis patients toward out-of-state products.
cityweekly.net - April 17 at 6:18 PM
Advance directives help people plan for their future medical care and quality of lifeAdvance directives help people plan for their future medical care and quality of life
msn.com - April 12 at 5:30 PM
2 Beaten-Down Stocks That Could Be Ready to Soar2 Beaten-Down Stocks That Could Be Ready to Soar
fool.com - April 11 at 5:33 AM
Utah Department of Agriculture unveils new analysis of Utahs Medical Cannabis marketUtah Department of Agriculture unveils new analysis of Utah's Medical Cannabis market
cachevalleydaily.com - April 9 at 4:39 PM
Intermountain Health’s Transplant Program and patients celebrate life-saving medical milestoneIntermountain Health’s Transplant Program and patients celebrate life-saving medical milestone
msn.com - March 14 at 10:05 PM
Utah at the forefront of Americas alarming prescription drug shortagesUtah at the forefront of America's alarming prescription drug shortages
ksl.com - March 12 at 6:37 PM
Utah at the forefront of America’s alarming prescription drug shortagesUtah at the forefront of America’s alarming prescription drug shortages
msn.com - March 11 at 9:12 PM
Utah Valleys 1st osteopathic college to host grand opening for innovative buildingUtah Valley's 1st osteopathic college to host grand opening for 'innovative' building
ksl.com - March 4 at 2:15 PM
Utah Medical Products, Inc.s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Utah Medical Products, Inc.'s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - March 4 at 8:49 AM
Utah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiumsUtah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiums
msn.com - March 3 at 9:18 AM
Utah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outageUtah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outage
msn.com - February 25 at 2:35 PM
Utah affected by E. coli contamination in raw milk cheeseUtah affected by E. coli contamination in raw milk cheese
news.yahoo.com - February 18 at 2:20 PM
Utah Medical Products, Inc. Announces Quarterly DividendUtah Medical Products, Inc. Announces Quarterly Dividend
finance.yahoo.com - February 6 at 12:42 PM
Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)
finance.yahoo.com - January 31 at 5:58 PM
Utah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUtah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finanznachrichten.de - January 30 at 7:07 PM
UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finance.yahoo.com - January 30 at 7:07 PM
Utah Medical Products Inc (UTMD) Reports Mixed 2023 Financial ResultsUtah Medical Products Inc (UTMD) Reports Mixed 2023 Financial Results
finance.yahoo.com - January 30 at 7:07 PM
Investors Could Be Concerned With Utah Medical Products (NASDAQ:UTMD) Returns On CapitalInvestors Could Be Concerned With Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
finance.yahoo.com - January 26 at 11:24 AM
Big changes made to Utah’s controversial bathroom bill, but concerns remainBig changes made to Utah’s controversial bathroom bill, but concerns remain
yahoo.com - January 25 at 4:01 AM
Should cold plunge tubs be regulated in Utah? Here’s what a legislative committee decidedShould cold plunge tubs be regulated in Utah? Here’s what a legislative committee decided
msn.com - January 20 at 12:12 AM
The magic behind the high-impact discoveries from Utah’s universitiesThe magic behind the high-impact discoveries from Utah’s universities
news.yahoo.com - January 19 at 7:12 PM
Utah Medical Products, Inc. (UTMD)Utah Medical Products, Inc. (UTMD)
finance.yahoo.com - January 17 at 3:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

GenMark Diagnostics logo

GenMark Diagnostics

NASDAQ:GNMK
GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the developing and commercializing molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company also offers Blood Culture Identification Gram-Positive and Negative panel, Blood Culture Identification Fungal Pathogen panel, and ePlex Gastrointestinal Pathogen Panel. In addition, it provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. Further, the company offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, thrombophilia risk test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test and eSensor SARS-CoV-2 Test. GenMark Diagnostics, Inc. sells its products through direct sales and technically specialized service organization in the United States, Europe, and internationally. The company was incorporated in 2010 and is headquartered in Carlsbad, California.
OrthoPediatrics logo

OrthoPediatrics

NASDAQ:KIDS
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
OraSure Technologies logo

OraSure Technologies

NASDAQ:OSUR
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
SI-BONE logo

SI-BONE

NASDAQ:SIBN
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Utah Medical Products logo

Utah Medical Products

NASDAQ:UTMD
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.